Questions discussed in this category
Does it factor into your decision making in the setting of restricted spirometry and normal lung volumes? Does this differ for SBRT v. chemoRT?
If a patient clearly has N1 disease with high SUV on PET, do you routinely recommend EBUS or mediastinoscopy to evaluate for N2 disease?
7225515843564292
Papers discussed in this category
Int. J. Radiat. Oncol. Biol. Phys., 2010-06-01
International journal of radiation oncology, biology, physics, 2013-03-01
Respir. Res., 2018 Apr 24